News

In type 1 diabetes, the body’s own immune system turns against the pancreas. Cells meant to protect you start destroying ...
Research led by the SKiN Center for Dermatology observed substantial clearance of scalp and body psoriasis and rapid itch ...
Roflumilast foam, 0.3% (Zoryve) used once-daily significantly improved itch and other symptoms of plaque psoriasis of the scalp and body, the phase III ARRECTOR trial showed.
Using an existing steroid-free topical foam daily significantly improved the signs and symptoms of psoriasis on the scalp and ...
KALAMAZOO COUNTY, MI –– One year has passed since an EF2 tornado tore through Portage and the surrounding townships on May 7, 2024. The tornado devastated homes — from mobile home parks in ...
Protagonist and J&J report strong Phase 3 psoriasis data for icotrokinra and unveil potent next-gen IL-17 blocker PN-881 at ...
The Kentucky investigation report, obtained by 13 Investigates, cites multiple failures before and after the murder that are now being addressed by the company. According to police reports and court ...
Imagine a giant box that emits a targeted laser, focusing on each spot of psoriasis. I knew my skin would likely get worse before it got better as part of this process, but I didn’t expect to be ...
Once-daily roflumilast foam significantly improves scalp and body psoriasis in 8 weeks and was well-tolerated in adolescents ...
Johnson & Johnson (JNJ) posts promising late-stage trial data for plaque psoriasis icotrokinra developed with Protagonist ...
Shares of Johnson & Johnson (JNJ) were in the spotlight on Friday morning after the company announced positive results from ...